Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet M Allen

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Seminars in Immunology|March 9, 2002
Phospholipase D and immune receptor signallingAlirio J Melendez, Janet M Allen
Experimental Parasitology|September 20, 2011
Receptor usage by the Acanthocheilonema viteae-derived immunomodulator, ES-62William Harnett, Helen S Goodridge, Janet M Allen, et al.
Diabetes Research and Clinical Practice|August 26, 2011
Closed-loop in children with type 1 diabetes: specific challengesDaniela Elleri, Janet M Allen, David B Dunger, et al.
British Journal of Pharmacology|August 18, 2004
Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanismClaire Jacob, Corinne Szilagyi, Janet M Allen, et al.
Journal of Diabetes Science and Technology|September 11, 2020
Training and Support for Hybrid Closed-Loop TherapyCharlotte K Boughton, Sara Hartnell, Janet M Allen, et al.
Immunology Letters|July 4, 2002
Differentiation of the human monocyte cell line, U937, with dibutyryl cyclicAMP induces the expression of the inhibitory Fc receptor, FcgammaRIIbAngus J M Cameron, Kenneth J McDonald, Margaret M Harnett, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathyKenneth J McDonald, Angus J M Cameron, Janet M Allen, et al.
Journal of Diabetes Science and Technology|February 20, 2010
Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetesMalgorzata E Wilinska, Ludovic J Chassin, Carlo L Acerini, et al.
Diabetologia|December 25, 2014
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialYue Ruan, Daniela Elleri, Janet M Allen, et al.
Immunology|October 18, 2002
C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI)Katherine B Bodman-Smith, Alirio J Melendez, Ian Campbell, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Seminars in Immunology|March 9, 2002
Phospholipase D and immune receptor signallingAlirio J Melendez, Janet M Allen
Experimental Parasitology|September 20, 2011
Receptor usage by the Acanthocheilonema viteae-derived immunomodulator, ES-62William Harnett, Helen S Goodridge, Janet M Allen, et al.
Diabetes Research and Clinical Practice|August 26, 2011
Closed-loop in children with type 1 diabetes: specific challengesDaniela Elleri, Janet M Allen, David B Dunger, et al.
British Journal of Pharmacology|August 18, 2004
Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanismClaire Jacob, Corinne Szilagyi, Janet M Allen, et al.
Journal of Diabetes Science and Technology|September 11, 2020
Training and Support for Hybrid Closed-Loop TherapyCharlotte K Boughton, Sara Hartnell, Janet M Allen, et al.
Immunology Letters|July 4, 2002
Differentiation of the human monocyte cell line, U937, with dibutyryl cyclicAMP induces the expression of the inhibitory Fc receptor, FcgammaRIIbAngus J M Cameron, Kenneth J McDonald, Margaret M Harnett, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathyKenneth J McDonald, Angus J M Cameron, Janet M Allen, et al.
Journal of Diabetes Science and Technology|February 20, 2010
Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetesMalgorzata E Wilinska, Ludovic J Chassin, Carlo L Acerini, et al.
Diabetologia|December 25, 2014
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialYue Ruan, Daniela Elleri, Janet M Allen, et al.
Immunology|October 18, 2002
C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI)Katherine B Bodman-Smith, Alirio J Melendez, Ian Campbell, et al.
Pageof 9